Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-24-000154

Director bought 10,000 shares at $1.09 ($10,900)

From the SEC's structured data for this filing

Trades in this filing

Jayasuriya Anula · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-29 Purchase : show line 1 in the form +10,000 $1.09 $10,900 10,000 D
Open-market purchases · 10,000 sh · avg $1.09 · $10,900
Loading xslF345X05/ownership.xml…